The difference between Pharmaceutical and Medical Device is not self-explanatory in some cases and cannot always be clearly answered by many experts. The distinction affects everything from regulatory pathways to clinical requirements, market access speed, and compliance costs.
Unlike the U.S. FDA, which clearly separates „drugs“ and „devices,“ the European system is guided by nuanced definitions under different sets of regulations. And in complex cases, the final classification may even be determined by a court ruling, including the European Court of Justice.
In the definitions of the respective laws and regulations, both product groups serve to “alleviate, prevent and treat illnesses”.
The legal framework for Medical Devices states: “…all substances and preparations of substances or other objects… that are intended by the manufacturer for use in humans by means of their functions for the purpose of detecting, preventing, monitoring, treating or alleviating diseases […] and whose intended primary effect in or on the human body is achieved neither by pharmacological or immunological means nor by metabolism, …”
The Medicinal Products Act defines Pharmaceutical as: “substances or preparations made from substances… that are intended for use in or on the human or animal body and are intended as agents with properties for healing or alleviating or preventing human or animal diseases or pathological complaints…”
Definition questions arise from the wording of the law, such as “intended primary effect”. In practice, this is defined by the so-called “intended purpose”. If this intended purpose is achieved neither pharmacologically, immunologically nor metabolically, the product in question may possibly be placed on the market as a Medical Device. In this case, we usually speak of “substantial Medical Devices” or also Borderline Medical Devices. A consumer with an average level of interest cannot, at first glance, tell the difference between these Pharmaceutical and Medical Device. Some examples would be laxatives based on macrogol or slimming products based on plant extracts. Similar cases also apply to the legal areas of food, food supplements, dietary foods, novel foods and functional food.
In order to simplify the classification and the distinction between Pharmaceutical and Medical Device in the respective legal areas, some interpretation aids on the subject have been published:
a) Guidance document: Classification of Medical Devices (2007 but still to some extent up-to-date, (c) AGMP Working Group)
b) MANUAL ON BORDERLINE AND CLASSIFICATION IN THE COMMUNITY REGULATORY FRAMEWORK FOR MEDICAL DEVICES, Section 4 highlights the difference between MD (Medical device) and Pharmaceutical Product (Drug) (European Union, here in version 1.18 from 2019. This guide is regularly updated. [If you are interested, we recommend googling the current version yourself.]
For products in the border area between pharmaceuticals, cosmetics and medical devices, we prepare classification analyses that we discuss with your notified body or the relevant authority to ensure legally compliant distribution of your products. Contact us for a non-binding and free-of-charge discussion to explore this possibility.
Support for US companies to enter the European market. EU Rep, Certification, QM System, Technical Documentation, support of the Procedure, selection of a Notified Body, support of the Certification Procedure, preparation of a Clinical Evaluation, support of Clinical Studies, including the Logistical Concepts.
WQS Management Consultants Inc
136 4th Street north, Suite 201
St Petersburg, Florida 33701
Telefon: (925) 212-7683
Email: werner@us.wqs.de
Web: us.wqs.de
Copyright 2024 WQS Management Consultants GmbH – All rights reserved